Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07662629

Addtional Effect of Hyperbaric Oxygen to Programmed Physical Activity on Musckoloskeletal Pain in Breast Cancer Elderly

patienst who survived from breast cancer are prescribed long administraion of aromatase inhbitors.. these inhibitors usually induce musckloskeletal pains. Programmed phsyical activity are reommended to improve these pains but effects of HYperbaric oxygen on these pain was not investigated

Recruiting

Interested in participating?

Request Info

Key information

Age range

65 year–75 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Cairo University

Dokki, Giza Governorate, 11432, Egypt

Location status: Recruiting

Location contact

ali AM Ismail, lecturer

CONTACT

[email protected]

+201005154209

About this study

forty elder survivors from breast cancer with musckolskeletal pains resultes from aromatase inhibitor intake were assigned to two groups, group I and group II. the groups received phsyical activity program (aerobci training on traedmill and strengtheining protcol thrice weekly fro 2 month) but group II additinally received one-hour hyperbaric therapy session , five times weekly for 2 month.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • braest cancer survivors
  • patients receiving aramatase inhibitor drugs
  • patients with musckolskeletal pains

Exclusion criteria

  • cardiac patients
  • respiratory patients
  • renal patients

Treatment and study plan

hyperbaric therapy and exercise

Other

Twenty elder survivors from breast cancer with musckolskeletal pains resultes from aromatase inhibitor intake received phsyical activity program (aerobci training on traedmill and strengtheining protcol thrice weekly fro 2 month) and additinally received one-hour hyperbaric therapy session , five times weekly for 2 month.

Exercise

Other

Twenty elder survivors from breast cancer with musckolskeletal pains resultes from aromatase inhibitor intake received phsyical activity program (aerobci training on traedmill and strengtheining protcol thrice weekly for 2 month).

Primary outcomes

  1. visual analogue scale

    Time frame: it will be measured after 2 months

    it self asessmant of pain level

Secondary outcomes

  1. worst pain

    Time frame: it will be measured after 2 months

    it is a subscore of brief pain inventory

  2. pain severity

    Time frame: it will be measured after 2 months

    it is a subscore of brief pain inventory

  3. pain related interference

    Time frame: it will be measured after 2 months

    it is a subscore of brief pain inventory

  4. pain score

    Time frame: it will be measured after 2 months

    it is a sub score of Western Ontario and McMaster Universities Osteoarthritis

  5. stifness score

    Time frame: it will be measured after 2 months

    it is a sub score of Western Ontario and McMaster Universities Osteoarthritis

  6. fucntion score

    Time frame: it will be measured after 2 months

    it is a sub score of Western Ontario and McMaster Universities Osteoarthritis

  7. total score of Western Ontario and McMaster Universities Osteoarthritis

    Time frame: it will be measured after 2 months

    it is usualy used in patients with arthritic pains

  8. Disabilities of the Arm, Shoulder and Hand questionnaire

    Time frame: it will be measured after 2 months

    the short form of it used in patients with arthritic pains

  9. fatigue severity scale

    Time frame: it will be measured after 2 months

    it is used to assess fatigue

  10. Short Physical Performance Battery

    Time frame: it will be measured after 2 months

    total score used to assess physical performance

Study contacts

Contact information is provided by the study sponsor or research team.

Ali MA Ismail, lecturer

CONTACT

[email protected]

01005154209

ali moahmed, lecturer

CONTACT

[email protected]

01031321109

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Addtion of Hyperbaric Oxygen to Programmed Physical Activity in Aromatse Inhibtors-linked Musckoloskeletal Pain in Breast Cancer Patients

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jun 23, 2026
Registry last updated
Jun 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.